MarketCap
Facebook
X
TelegramQuarterly report 2026-Q2
added 05-14-2026
cbdMD DPO Ratio 2011-2026 | YCBD
Annual DPO Ratio cbdMD
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68.6 | 84 | 78.4 | 70.1 | 73.4 | 69.1 | 121 | 65.8 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 121 | 65.8 | 78.8 |
Quarterly DPO Ratio cbdMD
| 2026-Q2 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.5 | 46.5 | - | 64.4 | 62.4 | 72 | - | 66.1 | 72.6 | 87.2 | - | 55.2 | 62.1 | 67.5 | 19.5 | 86.7 | 91.9 | 70.1 | 26.8 | 82.9 | 64.5 | 66.8 | 25.6 | 69.4 | 86.1 | 81.9 | 55 | 94.1 | 42.5 | 249 | 23.3 | 37.2 | 55.5 | 113 | 44.1 | 139 | 79.5 | 57.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 249 | 19.5 | 70.3 |
DPO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cumberland Pharmaceuticals
CPIX
|
889 | $ 5.87 | 6.53 % | $ 87.2 M |  USA |
 |
Endo International plc
ENDP
|
39.3 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
5.36 K | - | - | $ 36.6 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
38 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
4.75 K | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
345 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
116 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
352 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
309 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
212 | $ 2.74 | 0.37 % | $ 1.05 B |  Canada |
 |
Harrow Health
HROW
|
199 | $ 33.0 | 0.12 % | $ 1.21 B | USA |
 |
Athenex
ATNX
|
111 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
224 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
41.8 | - | - | $ 11.5 B | USA |
 |
Organogenesis Holdings
ORGO
|
94 | $ 2.66 | - | $ 337 M | USA |
 |
Pacira BioSciences
PCRX
|
37.3 | $ 23.35 | -0.55 % | $ 1.08 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
75.6 | - | -39.89 % | $ 27.7 M | USA |
 |
Bausch Health Companies
BHC
|
78.1 | $ 5.47 | 0.37 % | $ 2 B | Canada |
 |
Canopy Growth Corporation
CGC
|
52.8 | $ 1.04 | -2.8 % | $ 112 M | Canada |
 |
Tilray
TLRY
|
53 | $ 5.29 | -3.11 % | $ 3.27 B | Canada |
 |
Aurora Cannabis
ACB
|
-807 | $ 3.46 | -2.81 % | $ 190 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
32.3 | $ 1.1 | 3.77 % | $ 1.37 M | USA |
 |
Jupiter Wellness
JUPW
|
318 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
36.8 | - | 1.15 % | $ 7.11 M | USA |
 |
Evolus
EOLS
|
59.4 | $ 6.09 | -5.58 % | $ 393 M | USA |
 |
Emergent BioSolutions
EBS
|
65.2 | $ 8.45 | 0.96 % | $ 433 M | USA |
 |
Veru
VERU
|
251 | $ 2.35 | 5.86 % | $ 34.4 M | USA |
 |
Assertio Holdings
ASRT
|
122 | $ 23.44 | 0.3 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
45.4 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
274 | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
54.2 | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
6.63 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
194 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
20.2 | $ 0.73 | 3.0 % | $ 36.5 M | USA |
 |
Viatris
VTRS
|
70.9 | $ 16.65 | 1.15 % | $ 19.4 B | USA |
 |
Zomedica Corp.
ZOM
|
64.3 | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
15.4 | $ 0.79 | -2.06 % | $ 28.4 M | USA |
 |
China Pharma Holdings
CPHI
|
47.6 | $ 0.76 | -0.29 % | $ 3.26 M |  China |
 |
TherapeuticsMD
TXMD
|
723 | $ 2.12 | 0.47 % | $ 24.5 M | USA |